KLK6 has been implicated in EMT in breast cancer (Pampalakis et al., 2009), in gastric cancer by reducing the expression of E‐cadherin at the transcriptional level (Kim et al., 2012), and in colon cancer (Kim et al., 2011). This evidence concerns the gene CDH1 and breast carcinoma.